First Horizon Advisors, Inc. Supernus Pharmaceuticals, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.58 Billion
- Q3 2024
A detailed history of First Horizon Advisors, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,090 shares of SUPN stock, worth $41,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,090
Previous 1,090
-0.0%
Holding current value
$41,757
Previous $29,000
13.79%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.8MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$398 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$235 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$195 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$110 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$101 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.05B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...